KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio (2017 - 2025)

Regeneron Pharmaceuticals has reported Interest Coverage Ratio over the past 16 years, most recently at 72.12 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 72.12 for Q4 2025, down 23.52% from a year ago — trailing twelve months through Dec 2025 was 81.69 (up 12.99% YoY), and the annual figure for FY2025 was 81.69, up 12.99%.
  • Interest Coverage Ratio for Q4 2025 was 72.12 at Regeneron Pharmaceuticals, up from 53.2 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for REGN hit a ceiling of 299.86 in Q2 2025 and a floor of 46.67 in Q1 2024.
  • Median Interest Coverage Ratio over the past 5 years was 74.24 (2024), compared with a mean of 98.15.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 64.8% in 2022 and later surged 314.92% in 2025.
  • Regeneron Pharmaceuticals' Interest Coverage Ratio stood at 187.21 in 2021, then crashed by 64.8% to 65.91 in 2022, then dropped by 19.34% to 53.16 in 2023, then soared by 77.38% to 94.3 in 2024, then dropped by 23.52% to 72.12 in 2025.
  • The last three reported values for Interest Coverage Ratio were 72.12 (Q4 2025), 53.2 (Q3 2025), and 299.86 (Q2 2025) per Business Quant data.